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IL-1 has no direct role in the IGF-1 non- 
responsive state during experimentally induced 
arthritis in mouse knee joints
Pernette J Verschure, Leo A B Joosten, Fons A J Van de Loo, Wim B Van den Berg
Abstract Chondrocytes regulate the equilibrium between
Objective—To investigate the involvement synthesis and degradation of cartilage matrix 
of interleukin-1 (IL-1) in the induction or molecules in articular cartilage.1 Insulin-like 
maintenance o f the insulin-like growth growth factor 1 (IGF-1) is the most important 
factor 1 (IGF-1) non-responsive state of 
chondrocytes during experimental arthritis 
in mouse knee joints.
M ethods—To characterise IGF-1 non-
we
and
responsiveness during arthritis, 
measured chondrocyte proteoglycan (PG) 
synthesis by assaying incorporation of 
3SS-sulphate into mouse patellar cartilage, 
obtained from knee joints with experi­
mentally induced arthritis and normal 
knee joints, cultured with IGF-1. We 
investigated whether suppressive mediators 
produced by the arthritic synovium or 
chondrocytes abolished the IGF-1 stimu­
lation o f normal cartilage, and used IL-1 
primed cartilage to mimic the arthritic 
in vivo state. Specific inflammatory 
mediators responsible for the main­
tenance o f the suppressed IGF-1 response 
were sought. We measured IGF-1 
responsiveness in normal and arthritic We previously reported that, in contrast to the 
patellae cultured with antibodies against ability of IGF-1 to sustain chondrocyte PG 
tumour necrosis factor (TNF) or IL -la/ß , synthesis in normal mouse articular cartilage 
with IL-1 receptor antagonist (IL-lra), during culture, chondrocytes from experi- 
and with several inhibitors of proteolytic 
enzymes or reactive oxygen species, and 
analysed the role of IL-1 in the develop- non-responsiveness during arthritis was not 
ment of IGF-1 non-responsiveness by caused by general impairment of chondrocyte 
studying IGF-1 responses in cartilage metabolism.27 
treated with IL-1 antibodies in vivo, at the
anabolic growth factor for chondrocyte 
metabolism,2 7 whereas interleukin-1 (IL-1) is 
essential for chondrocyte catabolism.
In joint diseases such as rheumatoid arthritis 
(RA), protracted inflammation leads to severe 
destruction of the articular cartilage and 
injury of surrounding tissue. Degradation 
of the matrix proteoglycans (PGs) 
inhibition of PG synthesis are the main features 
of experimentally induced arthritis.13 There is 
compelling evidence that IL-1 and tumour 
necrosis factor (TNF) act as key mediators 
in the pathogenesis of inflammatory joint 
diseases.14“21 Moreover, IL-1 has been shown 
to be a key mediator in cartilage destruction, 
having a major effect on chondrocyte PG 
synthesis.22”26
A lack of anabolic signalling might con­
tribute to decreased chondrocyte PG synthesis 
during experimentally induced arthritis.27 2H
mentally induced arthritic knee joints did 
not respond to IGF-1.7 27 in This IGF-1
IL-1 and IGF-1 show counteracting activities:
for IGF-1 has been reported to
increase the recovery rate from IL-1 induced 
inhibition of chondrocyte PG synthesis,'1 to
onset of arthritis.
Results—Mediators from the surrounding 
tissue of both normal and arthritic
cartilage suppressed chondrocyte IGF-1 promote cartilage pathology by inhibiting
responses. Priming the cartilage with IGF-1 mediated anabolism,'2 to
IL-1 did not directly induce IGF-1 non- IGF-1 mRNA levels," and to induce secretion
responsiveness, but enhanced the ability of IGF binding proteins and increase IGF-1
of suppressive mediators from synovium receptor numbers.34 This suggests that the
or chondrocytes to downregulate the IL-1 induced inhibition of chondrocyte PG
IGF-1 responsive state. IL-lra, IL-lot/ß synthesis may act together with the defective
antibody, TNF antibody, or the inhibitors IGF-1 stimulation of chondrocyte PG syn-
tested did not markedly improve the thesis in experimental arthritis.
In the present study we investigated thedisturbed IGF-1 response, but treatment
with anti-IL-1 at the onset o f arthritis extent of IL-1 involvement in the IGF-1 non 
prevented the development of IGF-1 responsive state during experimentally induced
arthritis in mouse knee joints. We examinednon-responsiveness.
Conclusion—IL-1 alone does not induce the contribution of suppressive mediators
IGF-1 non-responsiveness and is not critical produced by the synovium that may abolish the
in the maintenance of this phenomenon. IGF-1 stimulation in in vitro culture systems,
However, IL-1 does appear to be an investigated a number of specific inflammatory
important cofactor in the generation of mediators produced in in vitro culture that may
the IGF-1 non-responsive state.
(Ann Rheum Dis 1995; 54: 976-982)
interfere with IGF-1 responsiveness, and 
analysed the role of IL-1 in the induction phase 
of IGF-1 non-responsiveness.
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Materials and m e t h o d s cartilage n  35 was used to study radiosulphate
ANIMALS incorporation, measured either directly at time 
Sexually mature female C57 black/6 mice zero (t = 0), reflecting the in vivo situation 
(8-12 weeks old, weights 20-25 g) were used, or after culture for 24 or 48 hours. Patellae 
The animals were kept under routine lab- were cultured in RPMI 1640 medium (Flow 
oratory conditions (21-22°C, relative humidity Laboratories Irvine, Scotland) supplemented 
60% and a 12 hour light-dark cycle), fed a with 2 mmol/1 glutamine, 40 [xg/ml gentamycin,
commercial pellet diet (RHM 
'he Netherlands), and given a<
tap water ad libitum.
and 0-1% ultrapure bovine serum albumin 
(Sigma) in the presence or absence of recom­
binant human IGF-1 (Boehringer Mannheim, 
Germany) in a concentration of 0-25 ag/ml,
INTRA-ARTICULAR I I -1 INJECTIONS
which is close to those in mouse plasma. The 
incubations were performed in 24 well cluster
Mouse recombinant IL-1 10 ng (kindly supplied dishes at 37°C in a humidified atmosphere 
by Dr I G Otterness, Pfizer Central Research, containing 5% carbon dioxide.
Groten, CT, USA) was injected in a volume of Suppressive mediators—The relative contri
6 |xl into the joint cavity of the right knee. The bution of suppressive mediators produced by
left contralateral joint an equal synovial tissue surrounding the patella specimen
volume of phosphate buffered saline (PBS), and by the patella specimen itself during 
The biological activity of IL-1 was determined culture was investigated by comparing cultures
using the NOB1 assay.““ The IL-1 batch was of patellae containing small amounts of 
stored at -20°C, and showed constant activity surrounding tissue with those of patellae 
over the period studied. The cartilage was containing large amounts of surrounding 
studied at day 1 after intra-articular injection tissue. In addition, cocultures of normal and
arthritic patellae were performed in 6-5 mm 
transwell systems with a porous cell culture 
insert (Costar, Cambridge, UK) and the 
i n d u c t i o n  o f  a r t h r i t i s  synthetic activity was measured in the cartilage
Arthritis was induced in mouse right knee of the normal patellae.
of IL-1.
joints by intra-articular injection of yeast IL-1 and TNF in vitro—To identify which
particles (180 |xg sterilised Zymosan) (Sigma, suppressive factors from the arthritic specimen 
St Louis, MO, USA) in pyrogen free saline, suppressed the IGF-1 response, patellae were 
This experimental arthritis model is charac- cultured in medium containing a mixture of
terised by the development (two to three days 
after induction of arthritis) of an exudate
rabbit antimouse antibodies against IL-1 ex and 
IL-lß (prepared in our own laboratory22),
containing large amounts of polymorpho- rat antimouse TNFot (Vlq hybridoma cells, 
nuclear cells in the joint space, by loss of kindly given by Dr Krammer, German Cancer 
cartilage PGs, and by inhibition of chondro- Research Center, Heidelberg, FRG). Re- 
cyte PG synthesis. Inflammation subsides within combinant human IL-1 receptor antagonist
damage (IL-lra) (Synergen, Boulder, Colorado, USA)
was included in some cultures, to examine 
whether its smaller size enabled it to gain 
access to the chondrocytes and exert a greater 
influence than the larger antibodies capable of 
poorer penetration of the articular cartilage. 
The concentrations of IL-lra, anti-IL-1, and 
anti-TNF used in the present study were based
a week and because the car 
is reversible, the matrix is 
repaired.n 27 In our subsequent experiments, 
therefore, cartilage was examined two days 
after Zymosan induction of arthritis.
IN VIVO A N TI-ri.-i TRHATMHNT
Anti-IL-1 treatment before the onset of 
has been shown to normalise the inhibition of
on those previously reported to exert positive
1,1 *" 11122 In the mixture of antibodies
chondrocyte observed during against IL-1 a and IL-lß were at
arthritis, but to have no effect on joint swelling concentrations of 0-06 mg/ml, while TNFa 
and cell influx.22 One hour before induction of antibody was used at 30 000 U/ml (1 U of the
intra- antibody has a neutralising capacity of 90 pgarthritis mice
venously with a standard dose of 0-6 mg/ml TNFa in the L929 bioassay). IL-lra was tested
purified rabbit antimouse IL-lu and IL-lß in a concentration range of 0-3-100 |j.g/ml. As
antibodies (prepared in our own laboratory by control for the IL-1 a, IL-lß, and TNFot anti-
A V de L; 1 jxg anti-IL-1 ot/ß consistently has bodies, patellae were cultured with rabbit IgGs
a total neutralising capacity of 50-100 pg of and rat IgGs.
both IL-1 subtypes tested in the NOB 1-assay22). Enzymes and reactive may
As a control, mice were injected intravenously induce changes in chondrocyte signalling and 
with rabbit IgG. thus interfere with IGF-1 responses, so 
patellae were also cultured in the presence or
absence of the inhibitors
CARTIIAGE CUI TURES (Boehringer) or recombinant human tissue
Mice were killed by cervical dislocation and inhibitor of metalloproteinases (TIMP) 
whole patellae were dissected from the right from AMGEN, Thousend Oaks, CA, USA), 
arthritic and left control knee joints, leaving the the oxygen scavenger, catalase, together with
cartilage fully intact.11 The patellae were 
isolated from the knee joints with minimal
horseradish peroxidase (Sigma) or the nitric 
oxide synthase inhibitor L-NG-monomethyl
amounts of surrounding tissue. The fully intact arginine (l-NMMA) (Calbiochem, San Diego,
978 Verschure, Joosten, Van de Loo, Van den Berg
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California, USA). The inhibitor concen­
trations we used (leupeptin 0*5 (xg/ml; TIMP A: Normal 
20 |xg/ml) were analogous to concentrations 
known to be effective.” '41 Catalase and horse­
radish peroxidase were used together in 
concentrations of 3 mg/ml and 12 mg/ml, 
respectively, and l-NMMA was used at 100 or 
1000 ixmol/1.
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IN VITRO INCORPORATION OF RADIOSULPHATE
Chondrocyte PG synthesis in patellar cartilage 
was measured by the incorporation of 
35S-sulphate as described previously.35 Briefly, 
cartilage was incubated in RPMI 1640 medium 
with 1-48 MBq 3,5S-sulphate (Na2” SO.v, Du 
Pont, ’s-Hertogenbosch, The Netherlands) for 
three hours at 37°C and then washed three 
times in physiological saline to remove non­
incorporated radiolabel. Patellae were then 
fixed in 4% buffered formaldehyde and de­
calcified in 5% formic acid for three hours, and 
the patellar cartilage removed from the 
surrounding tissue and digested in Lumasolve 
(Lumac, Landgraaf, The Netherlands) at 
60°C. The quantity of radioactive sulphate 
incorporated was assayed by liquid scintillation 
counting.13
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Statistical evaluation of the experiments was by 
one way analysis of variance in combination 
with Student’s t test. A p value <0-05 was 
considered to be significant.
Figure 1 In vitro response to IGF-1 iti normal (A) and 
arthritic (B) mouse patellar cartilage embedded in minimal 
or large amounts of surrounding tissue: chondrocyte PG  
synthesis of the cartilage ( iSS-sulphate incorporation) 
immediately after isolation of the patellae (t = 0) (  M) or 
after 24 hours culture with medium alone (Z \) or medium 
containing IGF-1 0-25 ¡xg/ml (I "). Data from three 
experiments (five patellae per group) presented as the 
mean (SEM ) percentage of the control value at t = 0. 
p  < 0-05 compared with radiosulphate incorporation 
* after culture with medium alone, and Rafter culture with 
IG F -1 in cartilage embedded in small amounts of 
sun
Results
IGF-1 NON-RESPONSIVENESS IN ARTHRITIC 
CARTILAGE
In keeping with previous observations, PG 
synthesis in patellar cartilage from normal knee 
joints declined to approximately 50% in 24
hour culture in the absence of IGF-1, whereas that IGF-1 stimulation of normal cartilage was 
metabolic activity was maintained or even reduced in the presence of arthritic specimens,
cyte PG
though a complete lack of IGF-1 responsive­
ness was not achieved (fig 2A).
In the cartilage of normal knee joints that 
and did not respond to was injected with IL-1 to mimic the in vivo
enhanced with physiological concentrations of 
IGF-1 (fig 1A).27 2() 30 Cartilage from arthritic 
knee joints demonstrated suppressed chondro-
further stimulation with IGF-1 (fig IB). This 
non-responsive state of arthritic chondro-
state of arthritic cartilage, PG synthesis was 
significantly reduced, but IGF-1 was able to 
cytes was maintained with supraphysiological enhance the synthetic rate in a subsequent 
concentrations of IGF-1 (2 |xg/ml; data not 24 hour culture period. However, when this 
shown). culture was performed in the presence of
arthritic patellae, a pronounced reduction of 
IGF-1 stimulation was noted. IGF-1 stimu-
SUPPRESSIVE m e d i a t o r s  lation of IL-1 primed cartilage cultured with
When the contribution of suppressive mediators arthritic patellae was not significantly different
produced during culture by the synovial tissue when compared with the ex vivo PG synthetic
surrounding the patella was investigated, it was rate of IL-1 primed cartilage (fig 2B). 
found that IGF-1 responses were significantly 
lower in both normal and arthritic patellar
cartilage embedded in large amounts of tissue r o l e  o f  i i . - i a n d  t n f  i n  v i t r o
(fig 1), indicating that substances in the Figure 3 shows the effect of IL-1 and TNF
surrounding tissue from both normal and modulation of the IGF-1 response. During 24
arthritic cartilage suppressed IGF-1 stimu- hours of culture, no significant effect was noted
lation of chondrocyte PG synthesis. for either cytokine, whereas the synthetic rate
Coculture studies of normal and arthritic was significantly greater when the IL-1 and 
patellae, in which the synthetic activity was TNF neutralising culture was extended to 48 
measured only in the normal cartilage showed hours, in both normal and arthritic specimens;
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Figure 2 Effect of coculture with mouse arthritic patellae 
on IGF-1 stimulation of chondrocyte PG  synthesis in 
normal (A) or IL-1 exposed (B) mouse patellar cartilage: 
radiosulphate incorporation determined immediately after 
isolation o f cartilage ( U ) ,  after culture with IGF-1 
0-25 /ag/ml alone (C l) , or after coculture for 24 hours with 
patellae isolated from normal ( \  ' )  or arthritic ( Ï S )  joints 
in medium containing 0-25 ¡xg/ml IGF-1. Data from three 
experiments (five patellae per group)  presented as the mean 
(SEM ). p  < 0-05 versus radiosulphate incorporation 
* after coculture with normal patellae, and fa r t = 0. 
Dashed lines ( —)  inserted to aid comparison of the effects 
of coculture with arthritic patellae versus 1 = 0 values 
(signijicant difference for normal cartilage; no significant 
difference for IL-1 primed cartilage).
K O L K  O l- ’ I L - 1  I N  V I V O
Further to our findings indicating that the use 
of antibodies against IL-1, TNF., or several 
inhibitors did not interfere with the IGF-1 
response during existing arthritis, we investi­
gated the IGF-1 responses in mice treated with 
IL-la/ß antibodies at the onset of arthritis, 
and found that anti-IL-1 treatment almost 
normalised ex vivo chondrocyte PG synthesis 
(fig 4). In the absence of IGF-1, PG synthesis 
declined, but culturing arthritic cartilage from 
anti-IL-1 treated mice with IGF-1 resulted in 
a highly significant stimulation of 
PG synthesis, suggesting their 
signalling had been averted.
INVOLVEMENT OF ENZYMES AND REACTIVE 
OXYGEN SPECIES
The table summarises the effects of several
oninhibitory
Leupeptin, an inhibitor of cysteine and serine 
proteinases, and TIMP, a well known metallo- 
proteinase inhibitor, did not affect IGF-1 
responses in a 24 hour culture period. 
Similarly, a combination of the oxygen radical 
scavengers, catalase and horseradish peroxidase, 
however, the IGF-1 stimulation in arthritic did not alter IGF-1 stimulation in normal or 
cartilage was marginal and PG synthesis arthritic cartilage. The potent nitric oxide 
remained clearly reduced compared with that synthase inhibitor, l-NMMA, in concen 
in normal cartilage. trations of 100 or 1000 |xmol/l also failed to
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Figure 3 Role of endogenous IL-1 or TNF in the IGF-1 response in pa tellar cartilage from normal (A) or arthritic (B) 
mouse knee joints: radiosulphate incorporation determined in cartilage after culture for 24 hours or 48 hours zotthout (  
or with neutralising antibodies against TNF (30 000 U/ml) ) ,  IL-1 a, and IL- l ß  (hath 0 0 6  mg/ml) (  11 >, or zmth 
IL -lra  10 ¡xg/ml in medium containing IGF-1 0*25 fig/ntl. IL-1 or TNF data: separate experiments with 
their individual controls; other data from three experiments (five patellae per group) presented as mean and SEM .
*p < 0*05 compared with radiosulphate incorporation after culture with IGF-1 alone.
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Figure 4 In vitro response to IGF-1 by patellar cartilage 
from arthritic joints of mice injected with a standard close 
of 0-6 mg/ml IL-1 a and I L- l ß  antibodies one hour 
before the onset of arthritis: chondrocyte PG synthesis 
C^S-sulphate incorporation) directly after isolation of the 
patella ft = 0) (M ) or after 2 4  hours culture in medium 
without (\I \) or with (  1 ')  IGF-1 0-25 ¡xg/ml, expressed 
as a percentage of the control value at t = 0 in normal 
cartilage. Representative results from experiments 
performed three limes (five patellae per experiment).
*p < 0-05 compared with radiosulphate incorporation 
after culture with medium alone.
affect either the IGF-1 stimulation in normal 
cartilage or the poor IGF-1 stimulation in 
arthritic cartilage.
Discussion
IGF-1 plays a key role in regulating chondro­
cyte biosynthetic functions.2'4 7 During experi­
mentally induced arthritis, articular cartilage 
does not respond to IGF-1 stimulation of 
chondrocyte PG synthesis,27 30 and this IGF-1 
non-responsiveness leads to the production of 
alternative PG monomers, which implies 
that IGF-1 is essential in the maintenance of 
cartilage integrity.10 Non-responsiveness of 
arthritic chondrocytes is not restricted to 
IGF-1 j but extends to other growth factors, 
such as basic fibroblast growth factor, platelet 
derived growth factor, epidermal growth factor, 
or transforming growth factor ß.2'1 This lack of
Effect of a selected range of inhibitors of proteolytic enzymes 
or reactive oxygen species in vitro on IGF-1 stimulation of 
chondrocyte PG  synthesis in cartilage from normal or 
a rthritic mouse k n ee jo in ts
No IGF-1 IGF-J
Normal patellae
RFMI medium 258 (24) 709 (65)
Leupeptin 233 (38) 820 (91)
TIM P 258 (41) 627 (27)
Catalase/HRPO 282 (34) 640 (88)
l-N M M A  100  jxmol/1 232 (40) 670 (70)
l-N M M A  1000  jxmol/I 251 (51) 859 (95)
rthritic patellae
RPMI medium 168 (46) 218 (87)
Leupeptin 171 (14) 187(44)
'PIMP 215 (36) 223 (30)
Catalase/HRPO 141 (34) 203 (42)
i.-NM M A 100 junoi/1 97 (64) 179(32)
I.-NM M A 1000 fxmol/1 115 (21) 164(20)
Data from three experiments (live patellae per group) presented 
as mean (SEM ).
TIM P ~  Tissue inhibitor of me taliopro teínas es; HRP O = horse­
radish peroxidase; l-N M M A  = i.-N°-m onom ethyl arginine.
anabolic signalling during arthritis may con­
tribute to destruction of the cartilage. In the 
present study we investigated the extent to 
which IL-1 is involved in the generation or 
maintenance of the IG F-1 non-responsive state 
during arthritis.
IL-1 is a potent inhibitor of chondrocyte PG 
synthesis and is thought to act as key mediator 
in the pathogenesis of cartilage destruction in 
arthritic disorders.9 10 1(1-18 In experimental 
arthritis models, IL-1 has been shown to be a 
more potent mediator of cartilage destruction 
than TN F.22“24 42 The present study has shown 
that unidentified mediators from the surround­
ing tissue of both normal and arthritic cartilage 
were able to suppress IGF-1 responses. Treat­
ment with IL-lra, IL-lot/ß antibodies, or 
TN F antibody did not abolish IGF-1 non­
responsiveness, suggesting that IL-1 or TNF 
are not the key mediators that maintain IGF-1 
non-responsiveness. The enhanced chondro­
cyte PG synthesis after culture of intact carti­
lage with anti-IL-1 and anti-TNF is probably 
specific for anticytokines, and may have 
reflected release of small amounts of cytokine 
from the tissue during its isolation. It is likely 
that the impact of the inflammatory process on 
the chondrocyte is complex and cannot be 
expected to be modulated by the elimination of 
one single factor. Although exposure of the 
cartilage to IL-1 did not in itself cause IGF-1 
non-responsiveness, the exposed cartilage 
became more susceptible to reduction of the 
IGF-1 response by other suppressive mediators 
in the synovium or the chondrocytes, when 
compared with the ex vivo PG synthetic rate of 
IL-1 primed cartilage. In addition, anti-IL-1 
treatment at the onset of arthritis abolished 
generation of IGF-1 non-responsiveness. 
These data imply that IL-1 has an important 
role in the onset of IGF-1 non-responsiveness 
but that, once the IG F-1 non-responsiveness is 
initiated, the importance of IL-1 is lost.
Degrading enzymes and reactive oxygen 
species have been implicated in the apparent 
breakdown of articular cartilage during joint 
inflammation.421,1 It is still not understood 
whether these degradative effects are achieved 
partly via inhibition of growth factor signalling. 
In this context, the absence of an IGF-1 
response could be the result of IG F-1 receptor 
stripping, or receptor damage caused by 
proteolytic enzymes or oxygen metabolites. 
Recent studies demonstrated positive effects of 
l-NMMA  and TIMP in patellae from arthritic 
knee joints. These inhibitors may be able to 
penetrate the cartilage matrix of diseased 
cartilage comparatively easily, in contrast to 
poor penetration to the chondrocytes in intact 
cartilage (A A J Van de Loo, in preparation). 
In the present study, we found that the 
metalloproteinase inhibitor, TIMP, and the 
serine and cysteine proteinase inhibitor, 
leupeptin, were unable to influence IGF-1 
responses in normal and arthritic cartilage. 
Moreover, the oxygen scavengers catalase and 
horseradish peroxidase, and the nitric oxide 
synthase inhibitor l-NMMA did not affect 
IGF-1 responsiveness. These data suggest that 
enzymes or oxygen species cannot be indicated
Verschure, Joosten, Van de Loo3 Van den Berg
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metabolism. Cartilage chondrocyte proteoglycan synthesis is dependent on the balance 
of anabolic effects of IGF-1 and catabolic effects of IL-1. During arthritis, chondrocyte 
PG synthesis is inhibited as a result of excess IL-1, which is sustained by IGF-1 
non-responsiveness. IL-1 is not able to induce IGF-1 non-responsiveness, but is indirectly 
involved (together with the unknown factor, X ) in generation of the phenomenon, as 
anti-IL-1 treatment can abolish development of IGF-1 non-responsiveness.
as key factors in IGF-1 non-responsiveness,— 
unless, perhaps, their inhibitors had been 
added to the culture system after irreversible 
damage had taken place. In keeping with the 
findings that enzymes or oxygen species do not 
have a key role in IGF non-responsiveness, we 
have shown previously that the transient 
chondrocyte IGF-1 non-responsiveness found 
after exposure to hydrogen peroxide was not 
related to IGF-1 receptor damage and that 
hydrogen peroxide mediated inhibition of 
chondrocyte PG synthesis was not associated 
with disturbed IGF-1 signalling.40 52 Moreover, 
we have also shown that IGF-1 receptors on 
the chondrocyte cell membrane were not 
decreased in amount during the stage of 
experimental arthritis in which IGF-1 non­
responsiveness is manifest.53 54 Thus it seems 
likely that joint inflammation impaired the 
process of chondrocyte receptor mediated 
signal transduction, causing a modified bio­
logical response. It is of interest that IGF-1 
non-responsiveness is not caused by total 
anergy of the chondrocytes, as forskolin—a 
stimulator of the adenylate cyclase pathway—is 
able to enhance chondrocyte PG synthesis in 
experimentally induced arthritic cartilage.27
IGF-1 binding proteins have an affinity for 
IGF-1 similar to that of the IGF-1 receptor, 
and increased production of IGF-1 binding 
protein may therefore diminish IGF-1 bio­
availability and affect IGF-1 non-responsiveness 
during arthritis.55“57 Dore et al57 demonstrated 
that the impaired biological response to IGF-1 
by articular chondrocytes from human osteo- 
arthritic cartilage was related to increased 
production of IGF binding proteins, though it
should be noted that ex vivo PG synthesis in 
osteoarthntic cartilage is at a supranormal level, 
in contrast with the suppressed chondrocyte 
PG synthesis in arthritic cartilage. We investi­
gated the non-responsiveness of arthritic 
chondrocytes in the presence of supra- 
physiological concentrations of IGF-1, to 
saturate all available IGF-1 binding proteins 
and thus exclude a role for excess binding 
proteins in our findings. The non-responsive 
state of arthritic chondrocytes was maintained 
in the presence of these supraphysiological 
concentrations of IGF-1 (2 |xg/ml), implicating 
inhibition of suppressive mediators produced 
by the cartilage or synovial tissue, or an 
intrinsic defect in IGF-1 signalling, rather 
than IGF-1 binding proteins, in the chondro­
cyte non-responsiveness. The possibility 
remains, however, that IGF binding proteins 
secreted in very high concentrations may be of 
importance.
In conclusion, lack of IGF-1 responses 
during arthritis are affected by a complex inter­
action of suppressive mediators (fig 5). 
Modulation of one individual mediator in the 
in vitro culture system does not influence the 
IGF-1 non-responsive state during arthritis. 
Priming of the cartilage with IL-1 is not fully  
responsible for IGF-1 non-responsiveness, but 
clearly makes the cartilage more susceptible to 
suppressive mediators. Moreover, anti-IL-1 
treatment at the onset of arthritis averts 
defective IGF-1 signalling. We propose that 
IL-1 does not induce IGF-1 non-responsive­
ness, but is involved indirectly in the 
generation of this phenomenon.
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